Citations

Clear

16280 citation(s) found for "Yu, David".

Comparison of [18F]MK6240 and [18F]Flortaucipir standardized uptake values (SUVs): the HEAD study
Tsai, Hsin‐Yeh, Tudorascu, Dana , Rahmouni, Nesrine , Servaes, Stijn , Stevenson, Jenna , Lowe, Val J. , Soleimani‐Meigooni, David N. , Oh, Hwamee , Jagust, William J., Baker, Suzanne L. , Tissot, Cécile , Tsai, Hsin‐Yeh, Lussier, Firoza Zubeida , Therriault, Joseph , Gordon, Brian A. , Pascual, Belén , Klunk, William E. , Rosa-Neto, Pedro , Pascoal, Tharick Ali

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093894 Get It

AbstractBackgroundDifferences between on‐ and off‐target retention characteristics between [18F]MK6240 and [18F]Flortaucipir (FTP) complicate the harmonization across tracers. Our objective here was to separate the impact of the reference region by evaluating correlations between [18F]MK6240 (MK) and [18F]FTP standard uptake values (SUVs).MethodParticipants (Figure 1, n=90) received an amyloid‐β (Aβ) PET scan ([11C]PIB or [18F]NAV4694) and two tau‐PET scans: [18F]MK (90‐110 minutes post‐injection) and [18F]FTP (80‐100 minutes post‐injection). For all PET scans, the individual frames were realigned, averaged, and co‐registered to a Freesurfer 7.1‐segmented T1‐MPRAGE. SUVs were calculated in the reference region (inferior cerebellar gray), on‐target regions (entorhinal cortex, hippocampus, Braak III, Braak IV, Braak V, Braak VI) and off‐target regions (caudate, pallidum, putamen, thalamus, cerebellar white matter, choroid plexus, meninges, eroded white matter). We examined correlations between [18F]MK and [18F]FTP SUV values as a function of Aβ status, as well as their associations with age.ResultAll correlations (Figure 2) were significant at p<0.001. The interaction with Aβ status was significant for hippocampus, BraakIII‐V and the metatemporal region. In Aβ+ participants, [18F]FTP and [18F]MK6240 have similar SUVs in on‐target regions with a slope close to 1 except for in hippocampus and Braak VI. However, [18F]FTP SUVs, on average, were greater than [18F]MK SUVs in Aβ+ and Aβ‐ subjects in the reference region and all off‐target regions except for meninges, and in Aβ‐ subjects in the on‐target regions. Age correlated with [18F]FTP SUVs in Aβ‐ subjects in all regions (except the reference region, Braak VI and meninges) and [18F]MK SUVs in putamen and pallidum, but this correlation was only significant (p<0.01) when young and old subjects were included.ConclusionDespite [18F]MK’s higher affinity for tau and SUVR dynamic range being twice that of [18F]FTP, the SUVs in on‐target regions are similar. The higher [18F]FTP signal in the reference region appears to be the contributing factor to the lower dynamic range. The higher [18F]FTP signal in on‐target regions for Aβ‐ subjects may reflect the presence of off‐target signals in these subjects. Taking off‐target signals into account should improve correlations between the two tracers, especially when measuring the earliest deposition of tau.
Plasma and MRI biomarkers predict post‐mortem tau pathology
Hu, Mingzhao, Przybelski, Scott A. , Fought, Angela J. , Rothberg, Darren M., Reichard, Ross R., Petersen, Ronald C. , Graff‐Radford, Jonathan, Moloney, Christina M. , Algeciras‐Schimnich, Alicia , Nguyen, Aivi T. , Dickson, Dennis W. , Knopman, David S. , Jack, Clifford R. , Mielke, Michelle M. , Graff‐Radford, Jonathan , Murray, Melissa E. , Vemuri, Prashanthi

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093893 Get It

AbstractBackgroundImaging and plasma markers are used as key indicators of disease for Alzheimer’s disease (AD) but their usefulness in predicting regional tau pathology is relatively understudied. Our objective was to construct predictive models for regional tau pathology measured on postmortem brain tissue using multiple ante‐mortem AD biomarkers. We focused on hippocampal and parietal regions that were immunostained with AT8 and 2E9 that reflect early and advanced aspects of tangle maturity, respectively.MethodsUsing autopsy data from 63 participants enrolled in the Mayo Clinic Study of Aging (MCSA) where the last clinical visit is within three years of death, we analyzed three ante‐mortem plasma markers ‐ phosphorylated tau protein at the threonine 181 residue, glial fibrillary acidic protein, total ß‐amyloid Aß42 relative to Aß40 ratio (Quanterix Simoa HD‐X Analyzer), and three regional MRI markers computed using SPM12 ‐ parietal thickness, parietal volume relative to total intracranial volume ratio, and hippocampal volume adjusted for total intracranial volume. Based on eight separate cross‐sectional linear regression models weighted by the inverse of time from last visit to death, we estimated the multiple and partial R2 predicting post‐mortem pathology measures, including AT8 and 2E9 in both the hippocampal and parietal regions. All models were adjusted for age, sex, and cardiovascular and metabolic conditions score.ResultsThe MRI models (R2 of 0.26‐0.53) had greater predictive power compared to the plasma models (R2 of 0.17‐0.26). The best multiple R2 was 0.53 for prediction of hippocampal AT8 using antemortem hippocampal volume adjusted for total intracranial volume followed by R2 of 0.43 for prediction of hippocampal 2E9 using hippocampal volume adjusted for total intracranial volume. Though the model prediction of parietal AT8 and 2E9 measurements was low (R2 of 0.21‐0.26), parietal thickness exhibited better predictive performance than parietal volume relative to total intracranial volume ratio.ConclusionsThe data we presented here may be utilized to validate biomarkers using regional pathology. Our results support that regional MRI is sensitive to tau pathology. Newer MRI methods should be tested to examine the specificity of newer quantitative measurements to tau pathology.
Comparing regional and global diffusion MRI markers as biomarkers of VCID
Raghavan, Sheelakumari , Przybelski, Scott A. , Kamykowski, Michael G. , Lesnick, Timothy G. , Graff‐Radford, Jonathan , Lowe, Val J. , Knopman, David S. , Petersen, Ronald C., Reid, Robert I. , Knopman, David S. , Jack, Clifford R. , Petersen, Ronald C. , Vemuri, Prashanthi

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093870 Get It

AbstractBackgroundQuantifying white matter using diffusion MRI (dMRI) has been proposed for measuring early microstructural tissue changes due to cerebral small vessel disease and aid in quantifying vascular contributions to cognitive impairment and dementia (VCID). Our goal was to compare the usefulness of longitudinal white matter changes in the commonly available diffusion MRI measures for VCID prevention trials.MethodWe included 718 participants over 50 years of age (mean age: 71.1(9.6) years) from the Mayo Clinic Study of Aging, a population‐based sample, with at least two dMRI scans and structural imaging. We computed the commonly available single‐shell dMRI measures (fractional anisotropy, mean diffusivity, and two MarkVCID measures ‐ free water and peak‐width skeletonized mean diffusivity [PSMD]) at each time point. We tested for voxel‐wise associations between dMRI markers and vascular risk measured by cardiovascular metabolic condition (CMC) and observed a region‐specific dependance across all dMRI measures. Using both global and regional dMRI measures, we (i) examined the longitudinal association of dMRI measures with cognition and (ii) computed sample size estimates for a hypothetical clinical trial. We also included white matter hyperintensities (WMH) and our previously proposed composite vascular white matter score (combination of WMH and fractional anisotropy of the genu) as a comparison.ResultVascular risk was associated with all single shell dMRI measures in the genu of the corpus callosum, which we included as a regional dMRI marker for comparison (Figure 1). All dMRI markers correlated with cognitive performance longitudinally (Table 1) and had comparable sample size estimates required for hypothetical VCID clinical trials (Figure 2). Further, global free water and the composite vascular white matter score had the smallest sample size estimates.ConclusionAll commonly used dMRI markers had significant frontal lobe changes due to vascular risk. Both global and regional corpus callosum dMRI markers were sensitive to longitudinal cognitive decline, suggesting their utility in measuring the slowing down of VCID. The composite vascular white matter score, global free water, and WMH show promise as VCID biomarkers. Further work is needed to validate these markers on multiple populations.
A Comparison of DTI‐Based Measures as Predictors of Future Cerebrovascular Degeneration
Przybelski, Scott A. , Lesnick, Timothy G. , Fought, Angela J. , Raghavan, Sheelakumari , Kamykowski, Michael G. , Graff‐Radford, Jonathan, Knopman, David S. , Petersen, Ronald C., Reid, Robert I. , Graff‐Radford, Jonathan , Knopman, David S. , Petersen, Ronald C. , Jack, Clifford R. , Vemuri, Prashanthi

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093860 Get It

AbstractBackgroundThere has been a recent proliferation of various quantities based on single shell Diffusion Tensor Imaging (DTI) for capturing overall cerebrovascular health, especially Small Vessel Disease (SVD) as a single number. The existing literature has gaps in the comparison of these measures, so we evaluated them as predictors of both current and future White Matter Hyperintensity (WMH) as a proxy of SVD.MethodUsing baseline 3T MRI examinations (T1, DTI, FLAIR scans) of 598 participants (>60 years, amyloid negative, to limit to those on the SVD pathway) from the Mayo Clinic Study of Aging, we calculated five summary DTI quantities with varying degree of complexity. We estimated their partial R2 from cross‐sectional linear regression models and computed semi‐partial R2 from mixed models predicting WMH volume as a percentage of Total Intracranial Volume (TIV). All models were adjusted for age, sex, and scanner model, and the WMH and based were log‐transformed before fitting. We also conducted subset analyses with high (WMH+) vs. low (WMH‐) baseline WMH load (cut at 1.62%) to compare the performance of the measures in early vs. widespread WMH.ResultAll MD‐based quantities computed on the whole brain, including FWF, performed similarly to each other, but Genu FA underperformed at explaining WMH variance (Table 1). PSMD (skeletonized or atlas based) was more sensitive in WMH+ but dramatically less so in WMH‐. In WMH‐ and overall cohort, FWF and JHU MD (which is a simple averaging of MD in the JHU atlas) performed well.ConclusionAll MD‐based measures performed similarly to each other in the whole dataset but dichotomizing by WMH load showed interesting differences. PSMD measurements are driven by the extreme end (95th percentile) of the MD distribution and therefore more sensitive in WMH+. Genu FA, a regional measure, was not useful for predicting whole brain WMH change. We noticed some variation in how the quantities are affected by scanner model (GE Signa HDxt and Discovery 750) which needs broader investigation. Simply averaging MD over WM avoids additional processing and is more sensitive to WM degeneration that is not (yet) severe.
Chronic Medical Conditions and Dementia Risk: Brain Age Models for Quantifying Impact and Understanding Mechanisms
Yu, Xi , Przybelski, Scott A. , Gebre, Robel K , Lesnick, Timothy G. , Vassilaki, Maria , Graff‐Radford, Jonathan, Petersen, Ronald C. , Reid, Robert I. , Graff‐Radford, Jonathan , Knopman, David S. , Jack, Clifford R. , Vemuri, Prashanthi

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093829 Get It

AbstractBackgroundChronic medical conditions increase dementia risk, and the mechanism may be captured computationally by measures of accelerated brain aging. We hypothesized that quantifying the impact of chronic conditions on GM and WM aging will aid in measuring the differential impact of each condition on brain aging and shed light on the mechanisms through which they increase dementia risk. We specifically focused on microstructural brain changes with Neurite Orientation Dispersion and Density Imaging (NODDI) based on advanced diffusion MRI ‐ neurite density index (NDI), free water fraction (FWF), and orientation dispersion index (ODI).MethodWe identified 1123 participants [913 cognitively unimpaired (CU), 114 with MCI, 96 with AD] from the Mayo Clinic Study of Aging (MCSA) and Mayo ADRC with multi‐shell diffusion MRI. MCSA participants had chronic medical conditions’ diagnosis (based on US Dept of HHS) extracted from the electronic health care records. Using the BorutaSHAP algorithm on NDI, ODI, and ISOVF features from GM and WM separately, we constructed two distinct brain age models for GM and WM. First, we evaluated the usefulness of the predicted age gap (PAG), which is the difference between predicted age by model and chronological age, for both WM and GM NODDI models in CU/MCI/AD. We then developed separate GM and WM models for each condition using samples from condition‐negative participants to compare PAG of GM and WM for that condition.ResultThere was greater PAG in GM (avg = ) than WM (avg = 9.15 yrs) in MCI/AD participants (Fig. 1A). Each condition shifted the GM PAG by 0.10 to 3.56 years and WM PAG by 0.38 to 3.72 years with stroke and congestive heart failure showing the greater PAG overall for GM and WM PAD respectively (Fig. 2). COPD, stroke, chronic kidney disease, hypertension had comparatively greater GM PAG than WM PAG; while hyperlipidemia, congestive heart failure and coronary artery disease had greater WM PAG than GM PAG (Fig. 1B).ConclusionChronic conditions are associated with increased GM and WM Brain aging models can aid in quantifying the impact of chronic conditions on dementia risk and understanding mechanisms.
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
White, Launia J. , Hendrix, Rachel , Ulrich, Jason D. , Henson, Rachel L. , Knight, William C. , Martens, Yuka A. , Wang, Ni , Starling, Skylar C , Ren, Yingxue , Asmann, Yan W. , Syrjanen, Jeremy A. , Vassilaki, Maria , Petersen, Ronald C. , Kanekiyo, Takahisa , Shue, Francis , Roy, Bhaskar, Xiong, Chengjie , Mielke, Michelle M. , Cruchaga, Carlos , Holtzman, David M. , Bu, Guojun , Heckman, Michael G.

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093743 Get It

AbstractBackgroundThe immune system is substantially involved in the development and progression of age‐related cognitive decline and Alzheimer’s disease (AD).MethodAs genetic and environmental factors interactively impact these conditions, we investigated how risk factors such as APOE genotype, age, and sex influence immune activation markers and AD biomarkers in cerebrospinal fluid (CSF) in elderly individuals enrolled in the Mayo Clinic Study of Aging cohort. Among cognitively unimpaired individuals aged over 65 at the baseline visit (N=298), we measured 365 CSF immune activation markers using the proximity extension assay.ResultWe found that age, sex, and diabetes status are associated with altered CSF levels of immune activation markers independently of other factors. For CSF AD biomarkers, we observed significant positive correlations between age and total tau, phosphorylated tau‐181 (p‐tau181), neurofilament light (NfL), and YKL40. APOE4 was also associated with lower Aß42 and higher SNAP25 in CSF. We further examined whether baseline visit variables can predict cognitive decline, represented by the conversion from CDR=0 to CDR>0. We found that age, Aß42, NfL, and REG4 were independently correlated with CDR conversion risk. When the cohort was dichotomized by their median values, older participants with lower Aß42, higher NfL, and higher REG4 at baseline developed cognitive impairment during the follow up with a c‐index of 0.762 while age alone had a c‐index of 0.699.ConclusionTogether, our results suggest that assessing CSF immune activation markers and AD biomarkers can improve the prediction of cognitive impairment risk in the elderly.
Comparison of tau‐PET tracers for in vivo Braak staging: the HEAD Study
Macedo, Arthur C. , Rahmouni, Nesrine , Servaes, Stijn , Wang, Yi‐Ting , Socualaya, Kely Monica Quispialaya, Lowe, Val J. , Oh, Hwamee , Soleimani‐Meigooni, David N. , Baker, Suzanne L. , Therriault, Joseph , Tissot, Cécile , Lussier, Firoza Zubeida , Arias, Jaime Fernández , Hosseini, Seyyed Ali , Ferreira, Pâmela C.L. , Bellaver, Bruna , Ferrari‐Souza, João Pedro , Aguzzoli, Cristiano Schaffer , Povala, Guilherme , Pascual, Belén , Gordon, Brian A. , Pascoal, Tharick Ali , Rosa-Neto, Pedro

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093737 Get It

AbstractBackgroundTau‐PET tracers allow for in vivo Braak staging of individuals in the Alzheimer’s disease (AD) continuum. The impact of tracers’ characteristics for Braak staging using tau‐PET remains unclear. Therefore, we performed a head‐to‐head comparison of Braak staging using first‐ and second‐generation tau‐PET tracers.MethodWe assessed 51 cognitively unimpaired (CU) and 49 cognitively impaired participants (mean [SD] age 69.4 [7.5] years) with at least two tau‐PET ligands ([18F]MK6240, [18F]AV1451, and/or [18F]RO948) at McGill University, as part of the HEAD study. We calculated standardized uptake value ratios (SUVR) in Braak‐like regions of interest (ROI) for each ligand and investigated their association using Spearman’s correlation. Thresholds defined the presence of tauopathy in each Braak ROI, which was used to assign a Braak stage to each participant. Finally, we assessed the agreement between the Braak staging provided by each tracer, both for the traditional (using separate Braak stages – 0, I, II, III, IV, V, and VI) and simplified (using joint Braak stages – 0, I‐II, III‐IV, and V‐VI) frameworks.ResultIn all Braak ROIs, we found positive correlations between the SUVR values of the three tracers (Fig. 1). The strongest correlation was between [18F]MK6240 and [18F]RO948 in Braak II (r=0.94), and the weakest between [18F]AV1451 and [18F]RO948 in VI (r=0.51). Inter‐tracer agreement regarding the latest stage of abnormality was substantial or nearly perfect between pairs of tracers but moderate between the three tracers (Fig. 2A). The simplified framework presented greater agreement compared to traditional Braak staging, except between [18F]MK6240 and [18F]RO948. At the ROI level, the lowest agreements were observed for Braak II and I‐II, when [18F]MK6240 and [18F]RO948 were compared to [18F]AV1451 (Fig. 2B‐C). [18F]AV1451 had the highest probability of overestimating the Braak stage assigned by [18F]MK6240 and by [18F]RO948, especially at earlier stages (Fig. 3).ConclusionThe ligands presented moderate to nearly perfect agreement for in vivo staging of AD severity. Off‐target binding of [18F]AV1451 to the choroid plexus might explain disagreements at early stages. Overall, slight improvements in agreements were achieved with the simplified framework, as observed in histopathological staging.
The Modifying Effects of Sex, Race, and Social Relationships on the Association between White Matter Integrity and Dementia Risk: The Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study
Eswaran, Surabhee, Liu, Albert C. , Palta, Priya, Sharrett, A. Richey , Groechel, Renee, Gottesman, Rebecca F. , Knopman, David S. , Koton, Silvia , Kucharska‐Newton, Anna , Liu, Chelsea , Lutsey, Pamela L. , Mosley, Thomas H. , Sullivan, Kevin , Walker, Keenan A. , Groechel, Renée C.

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093711 Get It

AbstractBackgroundWeakened white matter (WM) integrity is highly associated with dementia risk. Still, not everyone with WM changes develops dementia, suggesting the important role modifiable lifestyle factors may have in reducing dementia risk. We investigated how social relationships in mid‐life may modify the association between WM integrity and incident dementia risk within race and sex subgroups.MethodIn 1,679 Atherosclerosis Risk in Community (ARIC) study participants who were dementia‐free in mid‐life, psychosocial health was assessed via self‐reported questionnaires and participants were classified as having strong or poor social relationships in mid‐life (visit 2: 1990‐1992). Through diffusion tensor imaging, WM integrity was evaluated with 3T brain MRI (visit 5: 2011 – 2013); fractional anisotropy (FA) and mean diffusivity (MD) were estimated. Incident dementia cases were identified from visit 5 through December 31, 2019, with ongoing surveillance. Relative contributions of social relationships and WM integrity to incident dementia were evaluated in Cox‐proportional hazard regression models with race and race‐sex as interaction terms, and in stratified models (White Females, Black Females, White Males, Black Males).ResultSignificant three‐way interactions were observed between race, WM integrity, and mid‐life social relationships (p‐interaction<0.01). In Black participants with strong mid‐life social relationships, higher MD (hazard ratio (HR): 0.93, 95% CI: 0.63 – 1.38) and lower FA (HR: 1.25, 95% CI: 0.84 – 1.86) were not associated with the risk of dementia, although in Black participants with poor social relationships, higher MD remained a significant risk factor for dementia. However, across all White participants, higher MD and lower FA were associated with the risk of dementia, regardless of mid‐life social relationships (Table 1; Figure 1). Analysis of three‐way interactions between race‐sex, WM integrity, and mid‐life social relationships suggested that effect modification by mid‐life social relationships was most evident in Black Females, respective to other groups (Table 2; Figure 1).ConclusionThe contribution of WM integrity to dementia risk may be lower in Black participants with strong social relationships in mid‐life, particularly in Black Females. Further understanding of how contextual social factors may influence brain health in diverse populations should be examined in future studies and intervention efforts.
Connectivity as a universal predictor of tau spreading in typical and atypical Alzheimer’s disease
Bruin, Hannah de , Groot, Colin , ADNI, Barthel, Henryk , Bischof, Gérard N. , Brendel, Matthias, Dickerson, Brad C., Dyck, Christopher H van, Fredericks, Carolyn , Graff‐Radford, Jonathan, Hönig, Merle C., Jones, P Simon, Josephs, Keith A. , Katsumi, Yuta , Lee, Eddie B, McGinnis, Scott M., Mecca, Adam P. , Rahmouni, Nesrine , Servaes, Stijn , Sintini, Irene , Stevenson, Jenna , Touroutoglou, Alexandra , Trainer, Anne, Whitwell, Jennifer L., ADNI, Boellaard, Ronald , Brendel, Matthias , Cash, David M. , Coath, William , Day, Gregory S. , Doering, Elena , Drzezga, Alexander E. , Dyck, Christopher van , Eimeren, Thilo van , Flier, Wiesje M. van der , Fryer, Tim D. , Giessen, Elsmarieke van de , Gordon, Brian A. , Graff‐Radford, Jonathan , Hobbs, Diana A. , Höglinger, Günter U. , Irwin, David J. , Jones, Peter Simon , Xiong, Chengjie , Malpetti, Maura , Nasrallah, Ilya M. , O'Brien, John Tiernan , O’Dell, Ryan S. , Palleis, Carla , Perneczky, Robert , Phillips, Jeffrey S , Pijnenburg, Yolande A.L. , Putcha, Deepti , Rosa-Neto, Pedro , Rowe, James B. , Rullmann, Michael , Sabri, Osama , Saur, Dorothee , Schildan, Andreas , Schott, Jonathan M. , Schroeter, Matthias L , Therriault, Joseph , Visser, Denise , Weston, Philip S.J. , Whitwell, Jennifer , Wolk, David A. , Franzmeier, Nicolai , Ossenkoppele, Rik

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093663 Get It

AbstractBackgroundThere is a strong link between tau and progression of Alzheimer’s disease (AD), necessitating an understanding of tau spreading mechanisms. Prior research, predominantly in typical AD, suggested that tau propagates from epicenters (regions with earliest tau) to functionally connected regions. However, given the constrained spatial heterogeneity of tau in typical AD, validating this connectivity‐based tau spreading model in AD variants with distinct tau deposition patterns is crucial.MethodWe included 269 amyloid‐ß‐positive (PET/CSF) individuals with clinically diagnosed atypical AD (113 posterior cortical atrophy, PCA‐AD; 83 logopenic variant primary progressive aphasia, lvPPA‐AD; 33 behavioural variant AD, bvAD; 40 corticobasal syndrome, CBS‐AD) and 68 with typical AD from 12 international cohorts, who underwent tau‐PET (54% [18F]AV1451/[18F]flortaucipir/Tauvid, 27% [18F]MK6240, 19% [18F]PI2620). Using Gaussian mixture modeling including amyloid‐ß‐negative controls, cross‐sectional tau‐PET standardized uptake value ratios within Schaefer‐200 atlas regions were transformed to tau positivity probabilities. Tau epicenters were defined as the 5% regions with highest tau positivity probabilities. For each variant, the association between functional connectivity‐based distance (using the 30% strongest positive region‐to‐region connections of a group‐average connectivity matrix from ADNI elderly controls) and tau‐PET covariance (group‐average correlation per region pair) was assessed through linear regression, adjusting for age, sex, site, and Euclidean distance. Regions were categorized based on functional proximity to the epicenter (quartiles 1‐4) and tau positivity probabilities were assessed accordingly.ResultTau positivity probabilities matched clinical variants, with a posterior pattern in PCA‐AD, left‐hemispheric dominant pattern in lvPPA‐AD, widespread pattern in bvAD, sensorimotor cortex involvement in CBS‐AD, and temporo‐parietal predominance in typical AD (Fig.1). In line with this, tau epicenters were highly heterogeneous across variants (Fig.1). In all variants, greater tau‐PET covariance was associated with shorter functional connectivity‐based distance (Fig.2). We observed that regions in closer functional proximity to the epicenter exhibited higher tau positivity probabilities than regions functionally further away (p<0.05, Fig.3).ConclusionThis multi‐center study shows that the brain’s functional architecture serves as a universal predictor of tau spreading in AD. Since tau is a key driver of neurodegeneration and cognitive decline in AD, this finding holds potential for personalized medicine and defining participant‐specific endpoints in clinical trials.
Variational autoencoder latent space as a robust and pragmatic clinical classification tool for dementia
Wakefield, William C, Barnard, Leland R , Graff‐Radford, Jonathan, Petersen, Ronald C. , Lowe, Val J. , Botha, Hugo , Graff‐Radford, Jonathan , Kantarci, Kejal , Boeve, Bradley F. , Jack, Clifford R. , Jones, David T.

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093646 Get It

Abstract Background Many proposed clinical decision support systems (CDSS) require multiple disparate data elements as input, which makes implementation difficult, and furthermore have a black‐box nature leading to low interpretability. Fluorodeoxyglucose Positron Emission Tomography (FDG‐PET) is an established modality for the diagnosis of dementia, and a CDSS that uses only an FDG‐PET image to produce a reliable and understandable result would ease both of these challenges to clinical application. Method A deep variational autoencoder (VAE) was used to extract a latent representation of each image through prior training from FDG‐PET brain images (n=2000). This unsupervised VAE has a novel graph convolutional architecture that makes it applicable to masked template space images. A logistic regression model was used to classify each image. A parametric study of the latent space revealed the imaging features that were used in the logistic regression model to differentiate each class. A separate dataset of participants labeled with their clinical diagnosis (n=1239) was used to assess the logistic regression model’s diagnostic accuracy of cognitively unimpaired (CU) (n=679) and between common dementia subtypes: Alzheimer’s disease (AD) (n=310), Lewy body dementia (DLB) (n=151), and behavioral variant frontotemporal dementia (bvFTD) (n=99). The logistic regression classifier was evaluated using receiver‐operator characteristic (ROC‐AUC) curves. Result ROC‐AUC curves for CU and each dementia subtype are illustrated in Figure 1a. A k nearest neighbors model was used to develop a graphical representation of the latent space where nodes are images and edges are drawn between nearest neighbors, illustrated in Figure 1b. The graph of the latent space demonstrates a comparison between dementia subtypes and CU images. Conclusion In this study, we developed a proof‐of‐concept VAE that can achieve differential diagnosis with 84.8% balanced accuracy. The model architecture provides visual interpretability, and shows that the hippocampi, parietal lobes, and cerebellum, were useful for distinguishing AD, the frontal lobe, posterior cingulate cortex, and hippocampi were useful for distinguishing DLB, and prefrontal pole, subcortical structures, and occipital lobe were useful for distinguishing bvFTD. These regions of metabolism align with clinical pathology and metabolic patterns.